|
Market Closed -
Other stock markets
|
After hours 12:20:40 am | |||
| 58.10 EUR | +3.38% |
|
58.60 | +0.86% |
| 06:51pm | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 03:35pm | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 21.73x | 3.8x | -3.64x | 3.71x | 14.13x | 16.84x | 1.73% | 328.08Cr | |
| 34.57x | 21.09x | 0.74x | 12.36x | 25.86x | 26.91x | 0.58% | 1,03700Cr | |
| 27.4x | 6.96x | -1.78x | 6.26x | 17.33x | 18.83x | 2.1% | 62TCr | |
| 33x | 12608.26x | 0.15x | 7.49x | 15.4x | 15.88x | 2.71% | 45TCr | |
| 17.76x | 6.57x | 1.06x | 4.4x | 10.85x | 12.2x | 3.01% | 33TCr | |
| 21.11x | 6.17x | 17.08x | 5.63x | 13.79x | 14.87x | 2.84% | 29TCr | |
| 21.21x | 4.97x | 0.94x | 4.47x | 12.37x | 13.38x | 1.97% | 26TCr | |
| 14.09x | 6.22x | -9.17x | 5.24x | 10.8x | 12.71x | 3.55% | 22TCr | |
| 24.01x | 18.47x | 3.36x | 6.34x | 11.18x | 14.51x | 2.76% | 20TCr | |
| -46.95x | 8.23x | 0.33x | 5.62x | 31.09x | 62.21x | 2.53% | 16TCr | |
| 12.61x | 1.61x | 0.28x | 3.09x | 7.81x | 8.83x | 6.95% | 14TCr | |
| 11.8x | 5.33x | 0.24x | 3.23x | 8.69x | 9.34x | 4.15% | 12TCr | |
| 26.94x | 5.41x | 1.86x | 8.14x | 18.34x | 19.22x | -.--% | 12TCr | |
| 11.59x | 1.23x | 3.24x | 2.17x | 6.97x | 7.93x | 5.54% | 11TCr | |
| 12.04x | 4.4x | 0.97x | 2.71x | 7.84x | 8.96x | 3.64% | 10TCr | |
| 23.62x | 5.35x | 1.37x | 8x | 15.12x | 15.83x | 1.87% | 7.37TCr | |
| 44.68x | 1.19x | 23.98x | 2.75x | 9.73x | 27.83x | 3.68% | 5.44TCr | |
| 39.86x | 5.34x | 2.24x | 8.99x | 29.71x | 30.83x | 0.48% | 5.39TCr | |
| 20.3x | 1.65x | -0.12x | 1.71x | 8.12x | 13.63x | 0.49% | 5.27TCr | |
| Average | 19.55x | 669.59x | 2.27x | 5.39x | 14.48x | 18.46x | 2.66% | 23.1TCr | |
| Weighted average by Cap. | 23.16x | 1,295.16x | 1.44x | 7.12x | 16.96x | 19.53x | 2.28% |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
